Wholesale of pharmaceutical and medical goods
PHARMEX AS
Revenue 2025
NOK 41.8m
Operating profit
NOK 11.3m
Equity
NOK 8.5m
Incorporated
1999
Share capital
NOK 601,000
Key figures · 2025
Current ratio
1.56
Equity ratio
35.4%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 27.0% | |
| Net margin (%%) | 20.1% | |
| Return on assets (%%) | 47.1% | |
| Likviditet | ||
| Current ratio | 1.56 | |
| Working capital | 8.6m | |
| Soliditet | ||
| Equity ratio (%%) | 35.4% | |
| Debt-to-equity ratio | 1.82 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.